Navigation Links
Transgenomic Reports Fourth Quarter Financial Results
Date:2/24/2010

performance of Transgenomic for many years to come, as we added to and enhanced our platform technologies for use in drug discovery and in diagnostic screening.  The decision to execute the broad and exclusive license agreement with Dana-Farber Cancer Institute for Cold-PCR already is proving to be a wise one, as it gives us the ability to improve the sensitivity of a multitude of genetic tests while adding new ones to our product offerings.  For example, earlier this month we announced that in a study we conducted in conjunction with a major pharmaceutical company we validated Cold-PCR technology to detect colorectal tumor-associated K-RAS mutations with 100 percent concordance between Transgenomic's mutation results obtained in plasma and the matched tumor K-RAS genotypes. We will continue our validation studies throughout the year and develop additional cancer assays to complement our K-RAS kit for commercial use and for processing in both our CLIA-certified laboratory and pharmacogenomics laboratory as well as direct sales to end users.

"As personalized medicine continues to evolve, we are working with pharmaceutical companies and are in discussions with many more for the use of Cold-PCR to understand the mechanism of action of various drugs and the predictive value of a custom diagnostic assay. Cold-PCR has the potential to markedly improve patient care and earlier diagnosis of several diseases.

"We are assembling the building blocks that we believe ultimately will be a major force in the early diagnosis of Parkinson's disease. During
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR
2. Transgenomic, Inc. Executes License Option agreement for Parkinsons Disease Diagnostic Markers with Gene Solutions, LLC
3. Reminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
4. Webcast Alert: Transgenomic Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
5. Transgenomic Signs Exclusive License for Cold-PCR Technology From the Dana-Farber Cancer Institute
6. Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test
7. Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines
8. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
9. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2009 Financial Results
10. Par Pharmaceutical Companies Reports Adjusted EPS of $0.65 for Fourth Quarter 2009
11. Onyx Pharmaceuticals Reports Record Full Year and Fourth Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015  MiMedx Group, Inc. (NASDAQ: ... utilizing human amniotic tissue and patent-protected processes to ... the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, ... and corrected the multiple inaccuracies in the press ... regarding the recent rulings from the Patent Trial ...
(Date:8/27/2015)...  Hill-Rom Holdings, Inc., (NYSE: HRC ) invites ... Morgan Stanley Global Healthcare Conference on September 16, 2015, ... to listen to the live discussion via the internet ... https://cc.talkpoint.com/morg007/091615a_ae/?entity=49_UCJPU8N . A recorded replay of ... conclusion of the live event and accessible via the ...
(Date:8/27/2015)... 27, 2015 Major pharmaceutical and medical device companies ... conference in Philadelphia on Oct. 20, ... Tom Hagy of HB Litigation Conferences has announced. ... website at http://litigationconferences.com/?p=31886 The program is ... & Mahoney and Michelle Hart Yeary of Dechert ...
Breaking Medicine Technology:MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 2MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 3MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 4Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 2Pharmaceutical, Medical Device Law Seminar Features In-House, Outside Counsel 3
... Systems ( http://www.dcmsys.com ), healthcare IT company and teleradiology ... the Vendor Neutral Archive (VNA) vendor of choice by ... Dicom Systems, VNA works with any existing ... current storage to your PACS archive at any time, ...
... LANSING, Mich., Jan. 16, 2012  Neogen Corporation (NASDAQ: ... detect precise amounts of the mycotoxin zearalenone in grain ... wide variety of reproductive problems if eaten by livestock. ... to the company,s unequaled line of simple, quick, and ...
Cached Medicine Technology:ONRAD, Inc. Chooses Dicom Systems' Vendor Neutral Archive 2Neogen Develops Simple, Precise Test for Mold Toxin Zearalenone 2
(Date:8/27/2015)... ... 27, 2015 , ... In mid-May, Logistics Trust, Inc. (“Logistics ... launch of its Doobster platform, a HIPAA-compliant mobile application that allows medical marijuana ... phones and tablets. Well, Doobster, “The App That Delivers!” is here! ...
(Date:8/27/2015)... , ... August 27, 2015 , ... ... Summit , scheduled for October 27-29, 2015 in San Jose, CA. The ... will primarily focus on the void that exists where battery development and energy ...
(Date:8/27/2015)... ... ... In addition to its existing Doctor of Philosophy in Leadership and Doctor of ... campus in Reading: Doctor of Nursing Practice. , Alvernia’s Doctor of Nursing Practice ... the highest level of clinical nursing practice. , “Our vision is to graduate ...
(Date:8/27/2015)... ... ... Hospital North Pinellas, located at 1395 South Pinellas Avenue in Tarpon Springs, will open a ... be located at US Highway 19 North and Highlands Boulevard, less than eight miles from ... the project is slated to begin in September 2015. , The new 24-bed ...
(Date:8/27/2015)... ... August 27, 2015 , ... NetDimensions is once again named ... the platforms required not only to effectively deliver, curate and administer great programs, but ... Inc. , For six consecutive years, NetDimensions has maintained its position on this ...
Breaking Medicine News(10 mins):Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 2Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 3Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 4Health News:Doobster Launches a Nationwide, Comprehensive On-Demand Medical Marijuana App 5Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2Health News:Alvernia University Now Offering Three Doctoral Degree Programs 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 3Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 2Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 3
... estimate that fully 95 percent of our DNA represents ... the journal Cell researchers at The Wistar ... the discovery of the ability of long non-coding RNA ... long ncRNA molecules may represent so-called gene enhancer elementsshort ...
... used as a marker of health and well-being in unborn ... currently available to differentiate between a small, healthy fetus and ... significant limitations. What if they were improved? Would it save ... need medical intervention because their fetuses might just be small ...
... Fox Foundation for Parkinson,s Research announced awards totaling approximately ... pre-clinical therapeutic development projects. The funding includes $2.5 million ... Intervention Awards, one of the Foundation,s Edmond J. Safra ... the 2010 Clinical Intervention Awards are: , Charlotte ...
... Oct. 6, 2010 A set of proteins found ... way to diagnose Alzheimer,s disease, researchers at UT Southwestern Medical ... An analysis of the proteins, plus a clinical exam, ... percent accurate in ruling it out in people without the ...
... HealthDay Reporter , TUESDAY, Oct. 5 (HealthDay News) -- ... received ,hands-only, cardiopulmonary resuscitation (CPR) from a bystander were ... received no CPR or conventional CPR with mouth-to-mouth breathing. ... only is ,hands-only, CPR -- in which the rescuer ...
... Mozes HealthDay Reporter , TUESDAY, Oct. 5 (HealthDay ... apnea can subtly alter the shape of a patient,s face ... treatment, called continuous positive airway pressure (CPAP) can help relieve ... found possible craniofacial change [as a result of] long-term CPAP ...
Cached Medicine News:Health News:Wistar researchers discover new class of objects encoded within the genome 2Health News:Wistar researchers discover new class of objects encoded within the genome 3Health News:MFM researcher earns $3.7M NIH grant to study preterm birth 2Health News:MJFF announces over $10 million in funding for clinical and pre-clinical PD research 2Health News:Blood test could diagnose Alzheimer's disease, UT Southwestern researchers find 2Health News:'Hands-Only' CPR May Work Best for Cardiac Arrest 2Health News:'Hands-Only' CPR May Work Best for Cardiac Arrest 3Health News:'Hands-Only' CPR May Work Best for Cardiac Arrest 4Health News:Sleep Apnea Mask May Cause Subtle Facial Changes 2Health News:Sleep Apnea Mask May Cause Subtle Facial Changes 3
... and negative whole blood control to test ... solubility tests and hemoglobin electrophoresis. Sickle-Chex is ... manufacturers' solubility kits. Sickle-Chex is packaged in ... vial dispenses an accurate sample volume. No ...
... three-part differential control assayed for all parameters on ... Series, AcT/AcT diff/AcT diff2, MD Series and ONYX ... 1800; ABX Micros 60; and Diatron Abacus and ... stability of 30 days and a six-month closed-vial ...
... Cell-Chex Auto is a whole blood ... of hematology instruments that measure automated blood ... The assay provides total RBC and WBC ... and Sapphire, Beckman Coulter LH750/LH 755 (levels ...
iSleep 20i is an advanced high performance CPAP with outstanding self-adjusting i‑technology....
Medicine Products: